These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1311964)

  • 1. Neuroendocrine and behavioral responses to challenge with the indirect serotonin agonist dl-fenfluramine in adults with obsessive-compulsive disorder.
    McBride PA; DeMeo MD; Sweeney JA; Halper J; Mann JJ; Shear MK
    Biol Psychiatry; 1992 Jan; 31(1):19-34. PubMed ID: 1311964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain 5-HT function in obsessive-compulsive disorder. Prolactin responses to d-fenfluramine.
    Fineberg NA; Roberts A; Montgomery SA; Cowen PJ
    Br J Psychiatry; 1997 Sep; 171():280-2. PubMed ID: 9337985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anterior pituitary responds normally to protirelin in obsessive-compulsive disorder: evidence to support a neuroendocrine serotonergic deficit.
    Lucey JV; Butcher G; Clare AW; Dinan TG
    Acta Psychiatr Scand; 1993 Jun; 87(6):384-8. PubMed ID: 8356888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers.
    Hollander E; DeCaria CM; Nitescu A; Gully R; Suckow RF; Cooper TB; Gorman JM; Klein DF; Liebowitz MR
    Arch Gen Psychiatry; 1992 Jan; 49(1):21-8. PubMed ID: 1728249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine responses to challenge with dl-fenfluramine and aggression in disruptive behavior disorders of children and adolescents.
    Stoff DM; Pasatiempo AP; Yeung J; Cooper TB; Bridger WH; Rabinovich H
    Psychiatry Res; 1992 Sep; 43(3):263-76. PubMed ID: 1438624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenfluramine stimulation of prolactin in obsessive-compulsive disorder.
    Hewlett WA; Vinogradov S; Martin K; Berman S; Csernansky JG
    Psychiatry Res; 1992 Apr; 42(1):81-92. PubMed ID: 1603884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timing of neuroendocrine responses and effect of m-CPP and fenfluramine plasma levels in OCD.
    Hollander E; Cohen LJ; DeCaria C; Saoud JB; Stein DJ; Cooper TB; Islam NN; Liebowitz MR; Klein DF
    Biol Psychiatry; 1993 Sep; 34(6):407-13. PubMed ID: 8218609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma prolactin response to d-fenfluramine in obsessive-compulsive patients before and after fluvoxamine treatment.
    Monteleone P; Catapano F; Bortolotti F; Maj M
    Biol Psychiatry; 1997 Aug; 42(3):175-80. PubMed ID: 9232209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychopathology and personality characteristics in relation to blood serotonin in Tourette's syndrome and obsessive-compulsive disorder.
    Cath DC; Spinhoven P; Landman AD; van Kempen GM
    J Psychopharmacol; 2001 Jun; 15(2):111-9. PubMed ID: 11448084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noradrenergic function in obsessive-compulsive disorder: behavioral and neuroendocrine responses to clonidine and comparison to healthy controls.
    Hollander E; DeCaria C; Nitescu A; Cooper T; Stover B; Gully R; Klein DF; Liebowitz MR
    Psychiatry Res; 1991 May; 37(2):161-77. PubMed ID: 1876628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortisol response to d-fenfluramine in patients with obsessive-compulsive disorder and in healthy subjects: evidence for a gender-related effect.
    Monteleone P; Catapano F; Tortorella A; Maj M
    Neuropsychobiology; 1997; 36(1):8-12. PubMed ID: 9211437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fenfluramine challenge test in obsessive-compulsive disorder--first results.
    Pidrman V; Tůma I
    Acta Medica (Hradec Kralove); 1997; 40(4):99-102. PubMed ID: 9481883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin and cortisol responses to MK-212, a serotonin agonist, in obsessive-compulsive disorder.
    Bastani B; Nash JF; Meltzer HY
    Arch Gen Psychiatry; 1990 Sep; 47(9):833-9. PubMed ID: 2203327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin response to d-fenfluramine in obsessive-compulsive patients, and outcome of fluvoxamine treatment.
    Monteleone P; Catapano F; Di Martino S; Ferraro C; Maj M
    Br J Psychiatry; 1997 Jun; 170():554-7. PubMed ID: 9330023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced serotonergic responsivity following electroconvulsive therapy in patients with major depression.
    Shapira B; Lerer B; Kindler S; Lichtenberg P; Gropp C; Cooper T; Calev A
    Br J Psychiatry; 1992 Feb; 160():223-9. PubMed ID: 1540763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of serotonin in obsessive-compulsive disorder.
    Baumgarten HG; Grozdanovic Z
    Br J Psychiatry Suppl; 1998; (35):13-20. PubMed ID: 9829022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonergic function in social phobia: comparison to normal control and obsessive-compulsive disorder subjects.
    Hollander E; Kwon J; Weiller F; Cohen L; Stein DJ; DeCaria C; Liebowitz M; Simeon D
    Psychiatry Res; 1998 Jul; 79(3):213-7. PubMed ID: 9704868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower levels of whole blood serotonin in obsessive-compulsive disorder and in schizophrenia with obsessive-compulsive symptoms.
    Ma N; Tan LW; Wang Q; Li ZX; Li LJ
    Psychiatry Res; 2007 Feb; 150(1):61-9. PubMed ID: 17291595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects.
    Charney DS; Goodman WK; Price LH; Woods SW; Rasmussen SA; Heninger GR
    Arch Gen Psychiatry; 1988 Feb; 45(2):177-85. PubMed ID: 3337615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obsessions and Compulsions in Postpartum Women Without Obsessive Compulsive Disorder.
    Miller ES; Hoxha D; Wisner KL; Gossett DR
    J Womens Health (Larchmt); 2015 Oct; 24(10):825-30. PubMed ID: 26121364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.